Investing in healthcare private equity in a post-pandemic world (Insurance Investor)
Cameron Black, Chief Investment Officer at BCBS Arizona, shares how the firm is thinking about healthcare investment in the wake of Covid-19 and where the greatest opportunities lie.
Exact Sciences announces third quarter 2021 results (PR Newswire)
Exact Sciences announced that the company generated revenue of $456.4 million for the third quarter ended September 30, 2021, compared to $408.4 million for the same period of 2020.
Finding Biomarkers in IBD (HCP Live)
Patients with the absence of urgency had significantly greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.
Is telemedicine in GI here to stay? (MDedge)
Dr. Hernaez and Dr. Vaughn discuss the pros and cons of telemedicine in GI.
Is it the new office visit? Or simply just good enough for when we really need it?
11 Studies to Know From ACG 2021 (Medscape)
Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia reviews 3500 abstracts, plenaries presented at ACG 2021.
Video: Understanding the Evolving Role of Biosimilars in GI (Reach MD)
Biosimilars are making an impact in the GI field. Dr. Jennifer Caudle and Dr. Stephen Hanauer discuss the evolving role of biosimilars in anti-inflammatory care for GI patients.
Podcast- The Scope: Dr. Brian Dooreck on Diagnosing CRC (Gastroenterology & Endoscopy News)
Brian Dooreck, MD, of Pembroke Pines, Fla., explains why gastroenterologists can do a better job of communicating with their patients about a new diagnosis of CRC.
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.